ArticleHealth science reports2022

Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease?

Syeda Tayyaba Rehan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.